Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 2Recruiting 2Active not recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 12Hematologic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Urinary Bladder Neoplasms 4Leukemia, Myeloid, Acute 4Colorectal Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Myasthenia Gravis 3Multiple Myeloma 3Lung Neoplasms 3Kidney Neoplasms 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Heart Failure 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2Diabetes Mellitus, Type 2 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × INDUSTRY × Cognitive Dysfunction × Clear all
NCT06245031 2024-05-07

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Cognito Therapeutics, Inc.

Phase NA Enrolling by invitation
402 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡